TAZICEF
- Product NDC
- 0409-5092
- 11-digit product format
- 004095092
- Labeler code
- 0409
- Product ID
- 0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CEFTAZIDIME
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA064032
- Marketing category
- ANDA
- Marketing start
- 2006-05-08
- Substance
- CEFTAZIDIME
- Active strength
- 1 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TAZICEF
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFTAZIDIME | 1 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9M416Z9QNR |
| Rxcui | 1659283, 1659287, 1659292, 1659294 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0409-5092-11 | TAZICEF | 1 in 1 VIAL, PATENT DELIVERY SYSTEM | INJECTION, POWDER, FOR SOLUTION | 1 | | 29 |
| 0409-5092-16 | TAZICEF | 25 in 1 TRAY | INJECTION, POWDER, FOR SOLUTION | 25 | | 29 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFTAZIDIME | ACTIVE INGREDIENT | 9M416Z9QNR | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 14 | |
| CEFTAZIDIME ANHYDROUS | ACTIVE MOIETY | DZR1ENT301 | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 14 | |
| SODIUM CARBONATE | INACTIVE INGREDIENT | 45P3261C7T | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 14 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0409-5092 | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 29 | Current NDC, Legacy NDC, 2 package rows | 20211103_9b73979c-c95a-4433-0a9d-f9cea3cb557f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0409-5092-11 | 00409509211 | 1 in 1 VIAL, PATENT DELIVERY SYSTEM | | | | | Historical |
| 0409-5092-16 | 00409509216 | 25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5092-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5092-11) | 2006-05-08 | 0000-00-00 | No | No | Current |